Biological role of interleukin 1 receptor antagonist isoforms - PubMed (original) (raw)
Review
Biological role of interleukin 1 receptor antagonist isoforms
W P Arend et al. Ann Rheum Dis. 2000 Nov.
Abstract
The interleukin 1 receptor antagonist (IL1Ra) family of molecules now includes one secreted isoform (sIL1Ra) and three intracellular isoforms (icIL1Ra1, 2, and 3). Extensive evidence indicates that the sole biological function of sIL1Ra seems to be to competitively inhibit IL1 binding to cell-surface receptors. Although intracellular IL1Ra1 may be released from keratinocytes under some conditions, the intracellular isoforms of IL1Ra may carry out additional as yet poorly defined roles inside cells. Maintenance of a balance between IL1 and IL1Ra is important in preventing the development or progression of inflammatory disease in certain organs. Both the secreted and intracellular isoforms of IL1Ra contribute to maintenance of this balance. An allelic polymorphism in intron 2 of the IL1Ra gene (IL1RN*2) predisposes to the development or severity of a variety of human diseases largely of epithelial cell origin. Both the impaired production of IL1Ra and the overproduction of IL1beta are related to the presence of this allele. Restoration of the balance between IL1Ra and IL1 through a variety of approaches is a therapeutic goal in specific chronic inflammatory diseases.
Similar articles
- Interferon beta stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts.
Palmer G, Mezin F, Juge-Aubry CE, Plater-Zyberk C, Gabay C, Guerne PA. Palmer G, et al. Ann Rheum Dis. 2004 Jan;63(1):43-9. doi: 10.1136/ard.2002.005546. Ann Rheum Dis. 2004. PMID: 14672890 Free PMC article. - The balance between IL-1 and IL-1Ra in disease.
Arend WP. Arend WP. Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):323-40. doi: 10.1016/s1359-6101(02)00020-5. Cytokine Growth Factor Rev. 2002. PMID: 12220547 Review. - Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis.
Schiff MH. Schiff MH. Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i103-8. doi: 10.1136/ard.59.suppl_1.i103. Ann Rheum Dis. 2000. PMID: 11053099 Free PMC article. Review. - Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome.
Clarkson BDS, LaFrance-Corey RG, Kahoud RJ, Farias-Moeller R, Payne ET, Howe CL. Clarkson BDS, et al. Ann Neurol. 2019 Apr;85(4):526-537. doi: 10.1002/ana.25439. Epub 2019 Mar 8. Ann Neurol. 2019. PMID: 30779222 Free PMC article. - Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
Hallegua DS, Weisman MH. Hallegua DS, et al. Ann Rheum Dis. 2002 Nov;61(11):960-7. doi: 10.1136/ard.61.11.960. Ann Rheum Dis. 2002. PMID: 12379516 Free PMC article. Review.
Cited by
- Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectories.
Bhavani SV, Spicer A, Sinha P, Malik A, Lopez-Espina C, Schmalz L, Watson GL, Bhargava A, Khan S, Urdiales D, Updike L, Dagan A, Davila H, Demarco C, Evans N, Gosai F, Iyer K, Kurtzman N, Palagiri AV, Sims M, Smith S, Syed A, Sarma D, Reddy B Jr, Verhoef PA, Churpek MM. Bhavani SV, et al. Intensive Care Med. 2024 Oct 9. doi: 10.1007/s00134-024-07669-0. Online ahead of print. Intensive Care Med. 2024. PMID: 39382693 - Revelation of comprehensive cell profiling of primary and metastatic tumour ecosystems in oral squamous cell carcinoma by single-cell transcriptomic analysis.
Liao YH, Chen L, Feng BH, Lv W, Huang XP, Li H, Li CP. Liao YH, et al. Int J Med Sci. 2024 Aug 26;21(12):2293-2304. doi: 10.7150/ijms.97404. eCollection 2024. Int J Med Sci. 2024. PMID: 39310253 Free PMC article. - Changes in the innate immune response to SARS-CoV-2 with advancing age in humans.
Agrawal S, Tran MT, Jennings TSK, Soliman MMH, Heo S, Sasson B, Rahmatpanah F, Agrawal A. Agrawal S, et al. Immun Ageing. 2024 Mar 21;21(1):21. doi: 10.1186/s12979-024-00426-3. Immun Ageing. 2024. PMID: 38515147 Free PMC article. - MIF modulates p38/ERK phosphorylation via MKP-1 induction in sarcoidosis.
Talreja J, Peng C, Samavati L. Talreja J, et al. iScience. 2023 Dec 14;27(1):108746. doi: 10.1016/j.isci.2023.108746. eCollection 2024 Jan 19. iScience. 2023. PMID: 38299032 Free PMC article.
References
- J Exp Med. 2000 Jan 17;191(2):303-12 - PubMed
- J Immunol. 1995 Apr 15;154(8):4065-72 - PubMed
- Nature. 2000 Mar 23;404(6776):398-402 - PubMed
- J Clin Invest. 1990 May;85(5):1694-7 - PubMed
- Proc Natl Acad Sci U S A. 1991 May 1;88(9):3681-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources